The post US FDA Approved Novel Drugs for Year 2020 appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>No. | Active Ingredient | FDA-approved use on approval date* | Approval Date | ||
1 | Vibegron | To treat overactive bladder | 12/23/2020 | ||
2 | Ansuvimab-zykl | To treat ebola | 12/21/2020 | ||
3 | Relugolix | To treat advanced prostate cancer | 12/18/2020 | ||
4 | Margetuximab (anti-HER2 mAb | To treat HER2+ breast cancer | 12/16/2020 | ||
5 | Tirbanibulin | To treat actinic Keratosis of the face or scalp | 12/14/2020 | ||
6 | Berotralstat | To treat patients with hereditary angioedema | 12-03-2020 | ||
7 | Gallium 68 PSMA-11 | For detection and localization of prostate cancer | 12-01-2020 | ||
8 | Naxitamab-gqgk | To treat high-risk refractory or relapsed neuroblastoma | 11/25/2020 | ||
9 | Setmelanotide | To treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency, a rare disorder that causes severe obesity that begins at an early age | 11/25/2020 | ||
10 | Lumasiran | To treat hyperoxaluria type 1 | 11/23/2020 | ||
11 | Lonafarnib | To treat rare conditions related to premature aging | 11/20/2020 | ||
12 | Remdesivir | To treat COVID-19 | 10/22/2020 | ||
13 | Atoltivimab, Maftivimab, and Odesivimab-ebgn | To treat ebola virus | 10/14/2020 | ||
14 | Pralsetinib | To treat non-small lung cancer | 09-04-2020 | ||
15 | Copper Cu 64 dotatate injection | To help detect certain types of neuroendocrine tumors | 09-03-2020 | ||
16 | Somapacitan-beco | Growth hormone | 8/28/2020 | ||
17 | Clascoterone | To treat acne | 8/26/2020 | ||
18 | Satralizumab-mwge | To treat neuromyelitis optica spectrum disorder | 8/14/2020 | ||
19 | Viltolarsen | To treat Duchenne muscular dystrophy | 08-12-2020 | ||
20 | Oliceridine | To manage acute pain in certain adults | 08-07-2020 | ||
21 | Risdiplam | To treat spinal muscular atrophy | 08-07-2020 | ||
22 | Nifurtimox | To treat Chagas disease in certain pediatric patients younger than age 18 | 08-06-2020 | ||
23 | Belantamab mafodotin-blmf | To treat multiple myeloma | 08-05-2020 | ||
24 | Tafasitamab-cxix | To treat relapsed or refractory diffuse large B-cell lymphoma | 7/31/2020 | ||
25 | Abametapir | To treat head lice | 7/24/2020 | ||
26 | Decitabine and Cedazuridine | To treat adult patients with myelodysplastic syndromes | 07-07-2020 | ||
27 | Fostemsavir | To treat HIV | 07-02-2020 | ||
28 | Remimazolam | For sedation | 07-02-2020 | ||
29 | Triheptanoin | To treat molecularly long-chain fatty acid oxidation disorders | 6/30/2020 | ||
30 | Lurbinectedin | To treat metastatic small cell lung cancer | 6/15/2020 | ||
31 | Inebilizumab-cdon | To treat neuromyelitis optica spectrum disorder | 06-11-2020 | ||
32 | Flortaucipir F18 | Diagnostic agent for patients with Alzheimer’s disease | 5/28/2020 | ||
33 | Artesunate | To treat severe malaria | 5/26/2020 | ||
34 | Fluoroestradiol F18 | Diagnostic imaging agent for certain patients with breast cancer | 5/20/2020 | ||
35 | Ripretinib | To treat advanced gastrointestinal-stromal tumors | 5/15/2020 | ||
36 | Selpercatinib | To treat lung and thyroid cancers | 05-08-2020 | ||
37 | Capmatinib | To treat patients with non small cell lung cancer | 05-06-2020 | ||
38 | Opicapone | To treat patients with Parkinson’s disease experiencing “off” episodes | 4/24/2020 | ||
39 | Sacituzumab govitecan-hziy | To treat adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease | 4/22/2020 | ||
40 | Pemigatinib | To treat certain patients with cholangiocarcinoma, a rare form of cancer that forms in bile ducts | 4/17/2020 | ||
41 | Tucatinib | To treat advanced unresectable or metastatic HER2-positive breast cancer | 4/17/2020 | ||
42 | Selumetinib | To treat neurofibromatosis type 1, a genetic disorder of the nervous system causing tumors to grow on nerves | 04-10-2020 | ||
43 | Ozanimod | To treat relapsing forms of multiple sclerosis | 3/25/2020 | ||
44 | Osilodrostat | To treat adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease | 03-06-2020 | ||
45 | Isatuximab | To treat multiple myloma | 03-02-2020 | ||
46 | Rimegepant | To treat migraine | 2/27/2020 | ||
47 | Amisulpride | To help prevent nausea and vomiting after surgery | 2/26/2020 | ||
48 | Eptinezumab-jjmr | For the preventive treatment of migraine in adults | 2/21/2020 | ||
49 | Bempedoic acid | To treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C | 2/21/2020 | ||
50 | Lactitol | To treat chronic idiopathic constipation (CIC) in adults | 02-12-2020 | ||
51 | Tazemetostat | To treat epithelioid sarcoma | 1/23/2020 | ||
52 | Teprotumumab-trbw | To treat Thyroid eye disease | 1/21/2020 | ||
53 | Avapritinib | To treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) | 01-09-2020 |
The post US FDA Approved Novel Drugs for Year 2020 appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.
]]>